-
LRPPRC–Dasatinib Synergy in OXPHOS-Dependent Cancer
2026-08-24
The reference study identifies Dasatinib as a synergistic partner for LRPPRC inhibition and proposes a dual-genome mechanism of oxidative phosphorylation disruption. Its findings connect mitochondrial transcript destabilization with suppression of nuclear-encoded OXPHOS genes, offering a mechanistic rationale for combination treatment in LRPPRC-high tumors while highlighting important translational uncertainties.
-
HyperScript First-Strand cDNA Synthesis Kit: Colitis RT-qPCR
2026-08-23
The HyperScript First-Strand cDNA Synthesis Kit supports rigorous RNA-to-data workflows for inflammatory bowel research. This article connects the ROS–MAPK findings of a CeO2 colitis study with primer selection, structured-template reverse transcription, and defensible qPCR interpretation.
-
Oridonin, Inflammation, and Esophageal Cancer
2026-08-22
Peng et al. report that oridonin attenuated esophageal pathology and inflammatory signaling in a 4-NQO mouse model, with effects associated with suppression of the TLR4/NF-κB/NLRP3 inflammasome axis. The study connects systemic inflammatory markers, blood-cell indices, tissue pathology, and tumor-associated molecular readouts, offering a mechanistic basis for further validation rather than clinical evidence of efficacy.
-
Tankyrase Inhibition Suppresses HCC via Hippo Signaling
2026-08-22
The reference study shows that XAV-939 and G007-LK suppress hepatocellular carcinoma cell growth while reducing YAP activity through stabilization of the YAP inhibitors AMOTL1 and AMOTL2. Its main contribution is to connect tankyrase inhibition with Hippo pathway regulation, extending mechanistic analysis beyond the canonical Wnt/β-catenin context.
-
Oligo (dT) 25 Beads for Immune Transcriptomics
2026-08-21
How polyA-selective magnetic capture can strengthen immune transcriptomics and translational Alzheimer’s disease research while preserving a clear view of assay limitations.
-
Munc18c–Syntaxin4 Control of Tumor Cell Invasion
2026-08-20
The reference study identifies Munc18c as a functional regulator of syntaxin4 during invadopodium formation, linking SNARE-mediated membrane trafficking with extracellular matrix invasion. Its combination of interaction assays, targeted peptide interference, imaging, and trafficking measurements provides a mechanistic framework for studying how MT1-MMP and EGFR reach invasive tumor-cell membranes.
-
Plerixafor (AMD3100): A Platelet–Tumor Axis Lens
2026-08-20
Plerixafor (AMD3100) is more than a CXCR4 inhibitor for routine migration assays. This article explains how CXCL12 compartmentalization and platelet extravasation reshape experimental design for cancer metastasis inhibition, stem cell mobilization, and immune-cell trafficking research.
-
Recombinant Mouse Sonic Hedgehog Workflow Guide
2026-08-19
Build more controlled developmental assays with Recombinant Mouse Sonic Hedgehog, from alkaline phosphatase induction to genital-tubercle explant studies. The workflow connects dose-defined SHH protein exposure with comparative mouse–guinea pig evidence for studying morphogenesis and congenital malformation research.
-
Pioglitazone Workflows for PPARγ Research
2026-08-19
Pioglitazone enables controlled studies of PPARγ-dependent metabolism, macrophage polarization, and inflammatory signaling. This workflow-centered guide connects cell assays with DSS-induced intestinal inflammation while addressing solubility, controls, readouts, and cross-model interpretation.
-
Dimetridazole: From QS Signals to Assay Design
2026-08-18
Dimetridazole (1,2-Dimethyl-5-nitroimidazole) is best studied as a context-dependent antimicrobial and antivirulence tool. This article translates quorum-sensing, transcriptomic, combination, and infection-model evidence into a practical assay strategy.
-
A1 Versus AMD3100 in Colorectal Cancer
2026-08-18
Khorramdelazad and colleagues evaluated the fluorinated CXCR4 inhibitor A1 against AMD3100 using molecular simulations, CT-26 cell assays, and a BALB/c colorectal cancer model. A1 showed stronger computed receptor interactions and greater suppression of tumor growth, migration, regulatory T-cell infiltration, and immunosuppressive signaling, although the findings remain preclinical.
-
Dimetridazole: From Antimicrobial to Antivirulence
2026-08-17
Dimetridazole, also known as 1,2-Dimethyl-5-nitroimidazole, is gaining renewed interest as a research tool for connecting antimicrobial activity with quorum sensing, virulence control, biofilm formation suppression, and combination therapy. This thought-leadership analysis explains how to translate its strain-dependent biology into rigorous bacterial culture assays and infection model research without overstating the evidence.
-
EZ Cap EGFP mRNA 5-moUTP Workflow
2026-08-17
Use EZ Cap EGFP mRNA 5-moUTP as a bright, transient benchmark for delivery, translation, viability, and imaging studies. Its Cap1 structure, 5-moUTP chemistry, and approximately 100-nucleotide poly(A) tail help separate RNA-quality problems from vector, uptake, and intracellular-release limitations.
-
Leupeptin Hemisulfate Salt for Reliable Assays
2026-08-16
This scenario-based guide explains how Leupeptin, Microbial (Leupeptin hemisulfate), SKU A2570, can improve protease activity regulation and interpretation of cell-based and biochemical assays. It covers formulation, compatibility, preparation, controls, vendor selection, and limitations relevant to viability, proliferation, cytotoxicity, autophagy, and viral replication studies.
-
HyperScript™ Reverse Transcriptase for Assay Design
2026-08-15
Discover how HyperScript™ Reverse Transcriptase improves RNA to cDNA conversion when template structure, limited input, and transcript length challenge RT-qPCR. This article connects enzyme selection with target-specific assay architecture using recent Moloney murine leukemia virus research.